Results 21 to 30 of about 44,651 (208)

A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [PDF]

, 2019
Background The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was first described in 2012 and attracted a great international attention due to multiple healthcare associated outbreaks.
Al-Ali, Anfal Y., Al-Tawfiq, Jaffar A., Momattin, Hisham   +2 more
core   +1 more source

Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado

Arquivos de Gastroenterologia, 2006
BACKGROUD: Studies on hepatitis C virus kinetics showed that serum levels of interferon fall 48 h after drug administration, when viral load is increasing again.
Eduardo Lorens Braga, André Castro Lyra, Lourianne Nascimento, Eduardo Netto, Luciano Kalabrik, Luiz Guilherme Costa Lyra   +5 more
doaj   +1 more source

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis

Viruses, 2022
Ropeginterferon alfa-2b is a novel mono-pegylated and extra-long-acting interferon, being developed for the treatment of myeloproliferative neoplasm (MPN) and chronic viral hepatitis.
Yi-Wen Huang, Albert Qin, Chan-Yen Tsai, Pei-Jer Chen   +3 more
doaj   +1 more source

Interferon alfa-associated retinopathy

Journal of Osteopathic Medicine, 1997
Abstract Interferon alia and its related compounds have been used for more than 10 years in the treatment of a number of conditions including viral illnesses, childhood hemangiomas, various cancers, and leukemia. The potential applications for this class of medication continue to grow. The use of interferon alia in experimental protocols
R B, Chambers, A, Downie, B, Foote, F H, Davidorf   +3 more
openaire   +2 more sources

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort [PDF]

, 2016
BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings.
Abbas, Zaigham, Abdou, Ahmed Mohamed Saleh, Abou Rached, Antoine, Acalovschi, Monica, Afredj, Nawel, Ahlers, Silke, Ahmetagic, Sead, Ahn, Sang Hoon, Aissaoui, Magda, Akriviades, Euaggelos, Al Ghandoor, Zuhal, Al Gharabally, Abeer, Al Qameesh, Jihad, Alavian, Seyed Moayed, Alberto, Sara, Aleixo, Maria Jo\ue3o, Amedea, Alessandri, Amoroso, Pietro, Ancuta, Ioan, Andreica, Vasile, Andreoni, Massimo, Arama, Victoria, Ascione, Antonio, Askar, Haifa, Assene, Collins, Attili, Adolfo Francesco, Augustyniak, Krystyna, Baka Cwierz, Barbara, Bakalos, Georgios, Bandiera, Franco, Banyai, Tivadar, Basho, Jovan, Bassi, Paolo, Bastens, Boris, Bellantani, Stefano, Bellati, Giorgio, Berak, Hanna, Bevanda, Milenko, Bhalla, Ajay, Biglino, Alberto, Bocakova, Jana, Bourgeois, Stefan, Brixko, Christian, Brunetto, Maurizia, Bruno, Savino, Bunganic, Ivan, Calkic, Lejla, Caruntu, Florin, Casinelli, Katia, Castellacci, Roberto, Castelli, Francesco, Cattelan, Anna Maria, Chiriaco, Piergiorgio, Cijevschi, Cristina, Colletta, Cosimo, Colombo, Massimo, Colombo, Silvia, Coman, Felicia, Cool, Mike, Coppola, Carmine, Correa, Maria Cassia, Costa, Chiara, Craxi, Antonio, Curescu, Manuela, D'Amico, Emilio, D'Angelo, Salvatore, Daryani, Nasser Ebrahimi, De Galocsy, Chantal, Debzi, Nabil, Decaestecker, Jochen, Delic, Dragan, Delwaide, Jean, Demelia, Luigi, Derbala, Moutaz, Deron, Zbigniew, Di Giacomo, Antonio, Di Perri, Giovanni, Dimitroulopoulos, Dimitrios, Dohaibi, Ahmad, Drakoulis, Christos, Drenaggi, Davide, Elefsiniotis, Ioannis, Enyedi, Judit, Erne, Elke, Esmat, Gamal, Evgenidis, Nikolaos, Fabri, Milotka, Faria, Telo, Ferenci, Peter, Fernandes, Julio Cesar, Ferrari, Carlo, Ferraz, Maria Lucia, Fierbinteanu Braticevici, Carmen, Flisiak, Robert, Foster, Graham R., Foti, Giuseppe, Francisci, Daniela, Fried, Katalin, Gabr, Mamdouh, Ganga, Roberto, George, Christophe, Gervain, Judit, Gheorghe, Liana, Giannoulis, Grigoris, Gietka, Andrzej, Giguere, Alain, Gomide, Geisa, Guerreiro, Hor\ue1cio, Guessab, Nawal, Halota, Waldemar, Han, Sang Young, Hanno, Abdelfatah, Harxhi, Arjan, Hashmi, Zahid, Hassanein, Tarek, Hausinger, P\ue9ter, Henrion, Jean, Holoman, Jozef, Horsmans, Yves, Hoste, Paul, Houmani, Zaher, Hunyady, Bela, Ibrahimpasic, Nevzeta, Ionita Radu, Florentina, Ivanovski, Ljubomir, Jablkowski, Maciej, Jankovic, Goran, Janssens, Filip, Jarcuska, Peter, Jesic, Rada, Joksimovic, Nenad, Junior, Elson Martins, Juriens, Ir\ue8ne, Kanatakis, Stilianos, Karagiannis, Ioannis, Karatapanis, Stilianos, Ketikoglou, Ioannis, Kim, Yoonjun, Konstantinovic, Ljiljana, Krkoska, Dusan, Kupcova, Viera, Lakner, Lilla, Langlet, Philippe, Lasser, Luc, Laukens, Pierre, Lawate, Parimal, Lee, Yun Nah, Lefebvre, Veronique, Lencu, Monica, Lengyel, Gabriella, Lesch, Miklos, Lipczynski, Artur, Livia, Hara, Luaia, Rosang, Lyra, Andre, Macedo, Guilherme, Mahindad, Nadir, Mahiou, Hassene, Makkai, Erzs\ue9bet, Malhado, Jos\ue9, Manesis, Emmanuel, Mangia, Alessandra, Manolakopoulos, Spilios, Mansinho, Kamal, Martinet, Jean Paul, Masood, Siddiq, Matarazzo, Filippo, Mazur, Wlodzimierz, Mazzella, Giuseppe, Mazzeo, Maurizio, Megna, Angelo Salomone, Mela, Maria, Mello, Carlos Eduardo, Memoli, Massimo, Memon, Sadik, Mendes, Claudio, Merat, Shahin, Mesihovic, Rusmir, Michielsen, Peter, Miftode, Egidia, Mimidis, Konstantinos, Mohsin, Aftab, Montalbano, Marzia, Montalto, Giuseppe, Monteverde, Carlos, Motoc, Adriana, Mousoulis, Georgios, Mulkay, Jean Pierre, Musat, Marioara, Musialik, Joanna, Nagorni, Aleksandar, Nagral, Aabha, Nagy, Istvan, Nassiri Toosi, Mohsen, Nemes\ue1nszky, Elem\ue9r, Nevens, Frederik, Nikolopoulou, Vassiliki, Nozic, Darko, Olszok, Iwona, Olteanu, Dan, Oltman, Marian, Omar, Ashraf, Orfanou, Eleni, Orlandini, Alessandra, Orszulak, Grazyna, Ozsv\ue1r, Zs\uf3fia, Paik, Seung Woon, Parikh, Samir, Pascu, Oliviu, Passariello, Nicola, Patai, \uc1rp\ue1d, Peixe, Paula, Pelemis, Mijomir, Pereira, Patricia, Philip, Mathew, Picciotto, Antonio, Piekarska, Anna, Piekos, Tomasz, Pieri, Alessandro, Pietrangelo, Antonello, Pigozzi, Maria Graziella, Pirisi, Mario, Preotescu, Liliana, Quirino, Tiziana, Racz, Istvan, Radowska, Danuta, Raimondo, Giovanni, Ramos, Jos\ue9 Presa, Rao, Padaki, Rapaccini, Gian Ludovico, Reddy, K. Rajender, Reynaert, Hendrik, Ribiczey, P\ue1l, Rizzardini, Giuliano, Rizzetto, Mario, Robaeys, Geert, Roxo, Fausto, Ruiz, Fernando Jose, Russello, Maurizio, Russo, FRANCESCO PAOLO, Sabusco, Giuseppe, Santantonio, Teresa, Saracco, Giorgio Maria, Sarmento Castro, Rui, Schneider, Ferenc, Schreter, Ivan, Schuller, J\ue1nos, Serejo, F\ue1tima, Servais, Benoit, Shabanaj, Gentian, Sharara, Ala, Shiffman, Mitchell L., Sieklucki, Jerzy, Silaghi, Rodica, Silva, Giovanni, Silva, Mariliza Henrique, Simon, Krzysztof, Skladany, Lubomir, Soardo, Giorgio, Somani, Sanjay, Sood, Ajit, Spinzi, Giancarlo, Sporea, Ioan, Sprengers, Dirk, Stan, Marioara, Stanciu, Carol, Streinu Cercel, Adrian, Svorcan, Petar, Szalay, Ferenc, Szantova, Maria, Szentgy\uf6rgyi, L\ue1szl\uf3, Szlauer, Bronislawa, Tallarico, Ludovico, Teixeira, Rosangela, Todorovic, Zoran, Tolvaj, Gyula, Tornai, Istvan, Trifan, Anca, Tsianos, Epameinondas, Tundo, Paolo, Tusnadi, Anna, V\ue1czi, Zsuzsanna, Vafiadi Zoubouli, Irini, Valente, Cristina, Van Der Meersch, Filip, Van Vlierberghe, Hans, Varga, Marta, Varghese, Rosh, Varkonyi, Istvan, Velez, Jorge, Verhaz, Antonija, Verucchi, Gabriella, Vinci, Maria, Vincze, Aron, Vinelli, Francesco, Warakomska, Iwona, Warzee, Philippe, Yaghi, Cesar, Yang, Jinmo, Yousry, Ayman, Zaarour, Fouad, Zali, Mohammad Reza, Zignego, Anna Linda, Zuin, Massimo   +303 more
core   +1 more source

Tratamento de hemangioma gigante com interferon alfa: relato de dois casos Treatment of giant hemangioma with interferon-alpha: report of two cases

Revista Brasileira de Hematologia e Hemoterapia, 2007
O objetivo do trabalho é descrever o uso de interferon alfa no tratamento de pacientes com hemangioma gigante. Os autores relatam e analisam dois casos de hemangioma gigante em tratamento com interferon alfa. IBS, 3 anos, em acompanhamento no Ambulatório
Ana Julia Balau, Livia C. De Nadai, Mônica S. Bressan, Josiane L. Simão   +3 more
doaj   +1 more source

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment [PDF]

, 2010
Background Early detection of nonresponders to hepatitis C therapy limits unnecessary exposure to treatment and its side-effects. A recent algorithm combining baseline anti-NS4a antibodies and on-treatment quantitative PCR identified nonresponders to a ...
de Knegt, Robert J, Desombere, Isabelle, Haagmans, Bart, Hansen, Bettina, Janssen, Harry LA, Leroux-Roels, Geert, Orlent, Hans, Schalm, Solko W, Van Vlierberghe, Hans   +8 more
core   +1 more source

Tratamento clínico do linfangioma com alfa-2a-interferon Treatment of lymphangioma with interferon-alpha-2a

Jornal de Pediatria, 2001
OBJETIVO: descrever os resultados obtidos com o uso do alfa-2a-interferon no tratamento de pacientes pediátricos com linfangiomas irressecáveis ou refratários a outros tratamentos.
Reynaldo J.S.P. de Souza, Luiz G. Tone
doaj   +1 more source

Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications [PDF]

, 2015
One-fourth of individuals diagnosed with the human immunodeficiency virus concomitantly have the hepatitis C virus infection. Since the discovery of highly active antiretroviral therapy, liver complications have become the leading cause of morbidity and ...
Gandhi, Mona A., Kaur, Kirpal, Slish, Judianne   +2 more
core   +2 more sources

Erdheim Chester disease: a subtle quiddity; the first case reported from Nepal

Radiology Case Reports, 2020
Erdheim-Chester disease (ECD) is a rare entity throughout the world. This is the first case reported in Nepal. ECD is a rare aggressive, non-Langerhan's histocytosis of unknown origin with classical histological features.
Pawan Singh, MBBS, Roshani Shrestha, Narendra Kumar Yadav   +2 more
doaj   +1 more source